XML 47 R37.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

12 Months Ended

Jun. 30, 2012

The following table includes revenue for each reportable segment and reconciling items necessary to agree to amounts reported in the consolidated financial statements:



(in millions)	2012			2011			2010
Pharmaceutical	$	97,925		$	93,744		$	89,790
Medical	9,642			8,922			8,750
Total segment revenue	107,567			102,666			98,540
Corporate (1)	(15		)	(22		)	(37		)
Total consolidated revenue	$	107,552		$	102,644		$	98,503


(1)	Corporate revenue consists of the elimination of inter-segment revenue.

Segment Profit by Reportable Segment

The following table includes segment profit by reportable segment and reconciling items necessary to agree to amounts reported in the consolidated financial statements:



(in millions)	2012			2011			2010
Pharmaceutical	$	1,558		$	1,329		$	1,011
Medical	332			373			429
Total segment profit	1,890			1,702			1,440
Corporate	(98		)	(188		)	(133		)
Total consolidated operating earnings	$	1,792		$	1,514		$	1,307

Total Assets by Segment

The following table includes total assets at June 30, 2012, 2011 and 2010 for each segment as well as reconciling items necessary to total the amounts reported in the consolidated financial statements:



(in millions)	2012		2011		2010
Pharmaceutical	$	16,642	$	16,126	$	12,103
Medical	4,399		3,895		3,868
Corporate	3,219		2,825		4,019
Total consolidated assets	$	24,260	$	22,846	$	19,990

Revenue by Geographic Area

The following tables present revenue and net property and equipment for fiscal 2012, 2011 and 2010 by geographic area:



(in millions)	2012		2011		2010
United States	$	105,205	$	101,080	$	97,663
International	2,347		1,564		840
Total consolidated revenue	$	107,552	$	102,644	$	98,503

Property and Equipment, net by Geographic Areas



(in millions)	2012		2011		2010
United States	$	1,425	$	1,398	$	1,355
International	126		114		114
Total consolidated property and equipment, net	$	1,551	$	1,512	$	1,469

Depreciation and Amortization

Segment Reporting, Other Significant Reconciling Item

Reconciliation of Other Significant Reconciling Items from Segment to Consolidated

The following tables include depreciation and amortization and capital expenditures for fiscal 2012, 2011 and 2010 for each segment:



(in millions)	2012		2011		2010
Pharmaceutical	$	42	$	42	$	41
Medical	72		62		63
Corporate	211		209		150
Total depreciation and amortization	$	325	$	313	$	254

Capital Expenditure

Segment Reporting, Other Significant Reconciling Item

Reconciliation of Other Significant Reconciling Items from Segment to Consolidated



(in millions)	2012		2011		2010
Pharmaceutical	$	44	$	55	$	33
Medical	100		123		81
Corporate	119		113		146
Total capital expenditures	$	263	$	291	$	260

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations.

+ References+ Details

- Definition

Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.

+ References+ Details

- Definition

Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.

+ References+ Details